Manufacturers Life Insurance Company, The Rocket Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 154,687 shares of RCKT stock, worth $450,139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
154,687
Previous 152,489
1.44%
Holding current value
$450,139
Previous $1.92 Million
46.19%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding RCKT
# of Institutions
224Shares Held
105MCall Options Held
437KPut Options Held
117K-
Rtw Investments, LP New York, NY17.7MShares$51.5 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$36.7 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$17.8 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$15.1 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $220M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...